Thermo Fisher用4.1B美元购买Solventum的净化业务,以扩大生物生产。 Thermo Fisher buys Solventum's purification business for $4.1B to expand in bioproduction.

Thermo Fisher Scientific准备以41亿美元的价格收购Solventum的纯化和过滤业务，扩大其生物生产能力，预计将于2025年底完成。 Thermo Fisher Scientific is set to acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction capabilities and expected to close by the end of 2025. 收购的目的是促进生物医药、微电子学和其他部门的增长。 The acquisition aims to boost growth in biologic medicines, microelectronics, and other sectors. Thermo Fisher和Solventum的股票价格在宣布之后上涨。 Thermo Fisher's and Solventum's stock prices rose following the announcement.